Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Type 2 Diabetes Market From 2025 To 2029?
The market size of type 2 diabetes has witnessed remarkable growth in the recent past. The market, which is valued at $48.14 billion in 2024, is expected to rise to $51.47 billion in 2025 adhering to a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the historic period include changes in lifestyle and food habits, an increase in the elderly population, advancements in pharmaceuticals, and public health campaigns.
In the upcoming years, a significant increase is anticipated in the size of the type 2 diabetes market. This growth is projected to reach $71.31 billion by 2029, with a compound annual growth rate (CAGR) of 8.5%. Factors attributing to this growth in the forecasted period include the worldwide diabetes epidemic, advancements in technology, changes in healthcare policy and personalized medicine. Major trends from now until then would encompass digital health and telemedicine, preventive measures and early intervention, as well as artificial intelligence (AI), and machine learning (ML), and metabolic surgery.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp
What Are the Core Market Drivers Propelling Growth in the Type 2 Diabetes Industry?
The projected surge in the type 2 diabetes market is largely attributed to the escalating incidences of obesity and heart disease. Obesity is a health condition characterized by excessive accumulation of body fat to unhealthy extents, while heart disease distinguishes assorted conditions that affect the heart and blood vessels. Excessive body weight sparks insulin resistance, leading to elevated blood sugar levels which consequently cause type 2 diabetes. Similarly, increased blood sugar levels can wreak havoc on blood vessels and nerves that regulate the heart and blood vessels thereby catalyzing heart disease. For example, the Switzerland-based intergovernmental agency, World Health Organization (WHO), in March 2024, disclosed that approximately one in eight individuals globally were grappling with obesity. 2.5 billion adults (aged 18 years and above) were listed as overweight, with 890 million of them being identified as obese. Of the total adult population, 43% were labeled as overweight while 16% fell under the obese category. The count of overweight children below the age of 5 also touched the 37 million mark. Therefore, the climbing rates of obesity and heart disease form the backbone of the expansion of the type 2 diabetes market.
How Is the Type 2 Diabetes Market Segmented?
The type 2 diabetesmarket covered in this report is segmented –
1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors; Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists; Thiazolidinediones; Alpha-Glucosidase Inhibitors; Sulfonylureas And Other Insulin Secretagogues; Biguanides; SodiumGlucose Cotransporter 2 Inhibitors; Other Drug Classes
2) By Application: Glycemic Control; Cardiovascular Safety; Hypoglycemia Avoidance; Other Applications
3) By End-User: Children; Adults
Subsegments:
1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin; Saxagliptin; Linagliptin; Alogliptin
2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide; Semaglutide; Dulaglutide; Exenatide
3) By Thiazolidinediones: Pioglitazone; Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose; Miglitol
5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride; Glipizide; Glyburide
6) By Biguanides: Metformin
7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin; Dapagliflozin; Empagliflozin
8) By Other Drug Classes: Amylin Analogues; Bile Acid Sequestrants; Dopamine Agonists
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13050&type=smp
Which Regions Are Driving the Next Phase of the Type 2 Diabetes Market Growth?
North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Type 2 Diabetes Industry?
Leading firms in the type 2 diabetes market are creating groundbreaking products, one of which is Mounjaro, to ensure high safety and effectiveness for diabetes patients. The goal of pioneering drugs like Mounjaro is to improve the potency, safety, and ease of diabetes management surpassing current medications. The advancements in diabetes drug formulation are designed to optimize blood sugar control, reduce potential side effects, and cater to other associated health issues. For instance, Eli Lilly and Co., an American pharmaceutical entity, gained approval from the U.S. Food and Drug Administration, a government body in the US, in May 2022 for Mounjaro (tripeptide) injection. This innovation heightens blood sugar regulation in adult type 2 diabetes patients along with diet and exercise. Tirzepatide is an innovative, dual-action treatment for type 2 diabetes. This once-a-week injection targets two hormones that regulate blood sugar, namely glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 ameliorates insulin production and reduces glucagon production while GIP augments insulin production. Hence, Tirzepatide manifests as a formidable new treatment alternative for people suffering from type 2 diabetes, including those who haven’t adequately responded to other medications.
View the full report here:
https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report
How Is the Type 2 Diabetes Market Defined and What Are Its Core Parameters?
Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels due to insulin resistance and inadequate insulin production. The development of Type 2 diabetes is influenced by a combination of genetic, lifestyle and environmental factors. Dietary and pharmaceutical adjustments can manage type 2 diabetes by lowering weight, eating a healthy diet and exercising consistently.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13050
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model